Skip to main content
FinSpry Logo
FinSpry
ACRS logo
ACRS
(NASDAQ)
Aclaris Therapeutics, Inc.
$4.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aclaris Therapeutics, Inc. (ACRS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Aclaris Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(11 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$10.75
↑ 122.11% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ACRS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kate Dellorusso
LifeSci Capital
BuyInitiates
$13.00
Seamus Fernandez
Guggenheim
BuyReiterates
$12.00
Ram Selvaraju
HC Wainwright
BuyReiterates
$16.00
Biren Amin
Piper Sandler
BuyMaintains
$11.00
Alex Thompson CFA
Stifel Nicolaus
HoldMaintains
$4.00
Martin Fan
Wedbush
BuyMaintains
$10.00
Jeff Jones
Oppenheimer
BuyReiterates
$10.00
Adam Vogel
Craig-Hallum
BuyMaintains
$10.00
Martin Fan
Wedbush
BuyMaintains
$8.00 → $10.00
Jeff Jones
Oppenheimer
BuyInitiates
$10.00
Martin Fan
Wedbush
BuyReiterates
$8.00 → $8.00

Frequently Asked Questions

What is the analyst consensus rating for ACRS?

The analyst consensus rating for ACRS is "Buy" based on 8 analyst recommendations.

What is the average price target for ACRS?

The average 12-month price target for ACRS is $10.75, representing an upside of 122.1% from the current price of $4.84.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.